The Alzheimer’s Disease Neuroimaging Initiative (ADNI) unites researchers with study data as they work to define the progression of Alzheimer’s disease. ADNI researchers collect, validate and utilize data such as MRI and PET images, genetics, cognitive tests, CSF and blood biomarkers as predictors for the disease. Data from the North American ADNI’s study participants, including Alzheimer’s disease patients, mild cognitive impairment subjects and elderly controls, are available from this site.
Corrections to AV45 Analysis Results Error
An error has been found in the data reported in the AV45 Analysis Results table...
New data available for Aliquot Count in the LDMS DatabaseMore News >
New data available for Aliquot Count in the LDMS Database, version 2014-04-16. The dataset...